Since Immusoft was founded in 2009, it has participated in 10 rounds of funding. In total Immusoft has raised $49.7M. Immusoft's last funding round was on May 2024 for a total of $4.6M.
Immusoft has 9 investors, including Breakout Ventures, California Institute For Regenerative Medicine and California Institute for Regenerative Medicine. The latest investment occurred in May 2024.
